DAILYGLIM M2 (Glimepiride (2mg) + Metformin (500mg))

Dailyglim M2 Tablet PR is categorized within the anti-diabetic medication class and is specifically formulated to assist adults diagnosed with type 2 diabetes mellitus. This formulation combines two active ingredients aimed at effectively managing and stabilizing blood glucose levels in individuals experiencing diabetes. It is crucial to administer this medication alongside meals to optimize its efficacy. For consistent results, it is advised to take the tablet at the same time each day. Your healthcare provider will determine the appropriate dosage tailored to your needs, and adjustments may be necessary based on how well your blood sugar levels are being managed over time. Continuation of this treatment is essential, even if you feel healthy or your blood glucose appears to be well-regulated. Discontinuing the medication without medical counsel could lead to an elevation in blood sugar levels, potentially heightening the risk of severe complications such as kidney impairment, vision loss, nerve damage, and even the risk of amputation. It’s important to recognize that this medication should be part of a comprehensive treatment strategy that includes a nutritious diet, consistent physical activity, and weight management as guided by your healthcare provider. Personal lifestyle choices are integral to effective diabetes management. One of the most frequently reported adverse effects associated with Dailyglim M2 Tablet PR is a reduction in blood glucose levels (hypoglycemia). Awareness of hypoglycemia symptoms—such as excessive sweating, dizziness, headaches, and tremors—is essential, as is having quick-access sources of glucose like sugary snacks or fruit juices on hand. Alcohol consumption is discouraged as it may exacerbate the risk of low blood sugar. Additional possible side effects include alterations in taste, feelings of nausea, gastrointestinal discomfort, headaches, and infections in the upper respiratory tract. Some individuals may experience weight gain as a result of this medication. It is not advised for individuals with type 1 diabetes, diabetic ketoacidosis, or severe kidney or liver conditions. Prior to starting this medication, patients should disclose any history of heart disease to their doctor. Pregnant and breastfeeding women must also seek medical advice before commencing treatment. Regular monitoring of blood glucose levels and possible blood tests to evaluate blood cell counts and liver health are recommended while using this medication.